nodes	percent_of_prediction	percent_of_DWPC	metapath
Eplerenone—CYP3A5—Disulfiram—alcohol dependence	0.282	0.6	CbGbCtD
Eplerenone—CYP3A4—Disulfiram—alcohol dependence	0.11	0.234	CbGbCtD
Eplerenone—CYP3A4—Citalopram—alcohol dependence	0.0784	0.167	CbGbCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00552	0.0375	CbGpPWpGaD
Eplerenone—CYP11B2—Glucocorticoid biosynthesis—POMC—alcohol dependence	0.00541	0.0368	CbGpPWpGaD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00457	0.0311	CbGpPWpGaD
Eplerenone—CYP11B2—adrenal cortex—alcohol dependence	0.00446	0.0957	CbGeAlD
Eplerenone—CYP3A4—Felbamate Metabolism—CYP2E1—alcohol dependence	0.00436	0.0297	CbGpPWpGaD
Eplerenone—Hypothyroidism—Acamprosate—alcohol dependence	0.00408	0.0122	CcSEcCtD
Eplerenone—CYP11B2—cardiovascular system—alcohol dependence	0.00407	0.0874	CbGeAlD
Eplerenone—Coronary artery disease—Citalopram—alcohol dependence	0.00397	0.0119	CcSEcCtD
Eplerenone—Blood cholesterol increased—Citalopram—alcohol dependence	0.0039	0.0117	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00389	0.0264	CbGpPWpGaD
Eplerenone—Cerebrovascular disorder—Citalopram—alcohol dependence	0.00351	0.0105	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.0033	0.0225	CbGpPWpGaD
Eplerenone—CYP11B2—blood—alcohol dependence	0.00322	0.0691	CbGeAlD
Eplerenone—Sudden death—Citalopram—alcohol dependence	0.00307	0.0092	CcSEcCtD
Eplerenone—Blood glucose increased—Citalopram—alcohol dependence	0.00307	0.0092	CcSEcCtD
Eplerenone—Gamma-glutamyltransferase increased—Naltrexone—alcohol dependence	0.00301	0.00903	CcSEcCtD
Eplerenone—CYP3A5—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.00301	0.0205	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—ADH6—alcohol dependence	0.00293	0.0199	CbGpPWpGaD
Eplerenone—Neuropathy peripheral—Disulfiram—alcohol dependence	0.00291	0.00874	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.0029	0.0197	CbGpPWpGaD
Eplerenone—Hyperbilirubinaemia—Acamprosate—alcohol dependence	0.00288	0.00864	CcSEcCtD
Eplerenone—Urine abnormality—Citalopram—alcohol dependence	0.00283	0.00851	CcSEcCtD
Eplerenone—Hyperuricaemia—Acamprosate—alcohol dependence	0.00282	0.00847	CcSEcCtD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—ADH6—alcohol dependence	0.00279	0.019	CbGpPWpGaD
Eplerenone—CYP11B2—endocrine gland—alcohol dependence	0.00279	0.0599	CbGeAlD
Eplerenone—Creatinine increased—Acamprosate—alcohol dependence	0.00275	0.00825	CcSEcCtD
Eplerenone—Gastrooesophageal reflux disease—Naltrexone—alcohol dependence	0.00274	0.00823	CcSEcCtD
Eplerenone—Cholecystitis—Citalopram—alcohol dependence	0.00273	0.0082	CcSEcCtD
Eplerenone—Urine analysis abnormal—Citalopram—alcohol dependence	0.00267	0.00801	CcSEcCtD
Eplerenone—Blood uric acid increased—Acamprosate—alcohol dependence	0.00267	0.008	CcSEcCtD
Eplerenone—Hypoaesthesia—Disulfiram—alcohol dependence	0.00266	0.00797	CcSEcCtD
Eplerenone—Hypercholesterolaemia—Naltrexone—alcohol dependence	0.00262	0.00786	CcSEcCtD
Eplerenone—Hypothyroidism—Citalopram—alcohol dependence	0.00244	0.00734	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—ADH1A—alcohol dependence	0.00243	0.0165	CbGpPWpGaD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.0024	0.0163	CbGpPWpGaD
Eplerenone—Electrocardiogram abnormal—Citalopram—alcohol dependence	0.00239	0.00719	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00234	0.0159	CbGpPWpGaD
Eplerenone—CYP11B2—Endogenous sterols—POMC—alcohol dependence	0.00232	0.0158	CbGpPWpGaD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—ADH1A—alcohol dependence	0.00231	0.0157	CbGpPWpGaD
Eplerenone—Menstrual disorder—Citalopram—alcohol dependence	0.0023	0.00691	CcSEcCtD
Eplerenone—NR3C2—brainstem—alcohol dependence	0.0022	0.0473	CbGeAlD
Eplerenone—Influenza-like symptoms—Citalopram—alcohol dependence	0.0022	0.00659	CcSEcCtD
Eplerenone—Diabetes mellitus—Acamprosate—alcohol dependence	0.00218	0.00656	CcSEcCtD
Eplerenone—NR3C2—forebrain—alcohol dependence	0.00212	0.0456	CbGeAlD
Eplerenone—Vaginal haemorrhage—Citalopram—alcohol dependence	0.00212	0.00636	CcSEcCtD
Eplerenone—Ventricular arrhythmia—Citalopram—alcohol dependence	0.00212	0.00636	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—ADH4—alcohol dependence	0.00206	0.014	CbGpPWpGaD
Eplerenone—CYP3A7—Xenobiotics—CYP2E1—alcohol dependence	0.00206	0.014	CbGpPWpGaD
Eplerenone—Libido decreased—Acamprosate—alcohol dependence	0.00205	0.00615	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.00204	0.0139	CbGpPWpGaD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.00201	0.0137	CbGpPWpGaD
Eplerenone—CYP11B2—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.00199	0.0135	CbGpPWpGaD
Eplerenone—NR3C2—adrenal cortex—alcohol dependence	0.00197	0.0423	CbGeAlD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—ADH4—alcohol dependence	0.00197	0.0134	CbGpPWpGaD
Eplerenone—Libido decreased—Naltrexone—alcohol dependence	0.00194	0.00582	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.00194	0.0132	CbGpPWpGaD
Eplerenone—Hyponatraemia—Acamprosate—alcohol dependence	0.00191	0.00572	CcSEcCtD
Eplerenone—Gamma-glutamyltransferase increased—Citalopram—alcohol dependence	0.00191	0.00572	CcSEcCtD
Eplerenone—Atrial fibrillation—Naltrexone—alcohol dependence	0.0019	0.00569	CcSEcCtD
Eplerenone—Endocrine disorder—Citalopram—alcohol dependence	0.00189	0.00568	CcSEcCtD
Eplerenone—CYP3A7—endocrine gland—alcohol dependence	0.00189	0.0406	CbGeAlD
Eplerenone—Disturbance in sexual arousal—Acamprosate—alcohol dependence	0.00189	0.00566	CcSEcCtD
Eplerenone—Breast pain—Citalopram—alcohol dependence	0.0018	0.0054	CcSEcCtD
Eplerenone—NR3C2—cardiovascular system—alcohol dependence	0.0018	0.0386	CbGeAlD
Eplerenone—Cardiovascular disorder—Citalopram—alcohol dependence	0.00179	0.00536	CcSEcCtD
Eplerenone—Disturbance in sexual arousal—Naltrexone—alcohol dependence	0.00178	0.00535	CcSEcCtD
Eplerenone—Blood creatinine increased—Acamprosate—alcohol dependence	0.00178	0.00534	CcSEcCtD
Eplerenone—Progesterone—OPRK1—alcohol dependence	0.00177	0.697	CrCbGaD
Eplerenone—CYP11B2—Biological oxidations—ADH7—alcohol dependence	0.00176	0.0119	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of steroid hormones and vitamin D—POMC—alcohol dependence	0.00174	0.0118	CbGpPWpGaD
Eplerenone—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00174	0.00521	CcSEcCtD
Eplerenone—Orthostatic hypotension—Acamprosate—alcohol dependence	0.00174	0.00521	CcSEcCtD
Eplerenone—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00173	0.00518	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00171	0.00513	CcSEcCtD
Eplerenone—CYP3A7—liver—alcohol dependence	0.00171	0.0366	CbGeAlD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.00169	0.0115	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—GGT2—alcohol dependence	0.00168	0.0114	CbGpPWpGaD
Eplerenone—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00168	0.00503	CcSEcCtD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—ADH7—alcohol dependence	0.00167	0.0114	CbGpPWpGaD
Eplerenone—Dehydration—Naltrexone—alcohol dependence	0.00167	0.00502	CcSEcCtD
Eplerenone—Hypercholesterolaemia—Citalopram—alcohol dependence	0.00166	0.00498	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00165	0.0112	CbGpPWpGaD
Eplerenone—Fatigue—Disulfiram—alcohol dependence	0.00163	0.00491	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.00163	0.0111	CbGpPWpGaD
Eplerenone—Eosinophilia—Acamprosate—alcohol dependence	0.00163	0.00488	CcSEcCtD
Eplerenone—Pain—Disulfiram—alcohol dependence	0.00162	0.00487	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00162	0.00486	CcSEcCtD
Eplerenone—Angina pectoris—Acamprosate—alcohol dependence	0.0016	0.0048	CcSEcCtD
Eplerenone—Blood uric acid increased—Citalopram—alcohol dependence	0.0016	0.0048	CcSEcCtD
Eplerenone—Musculoskeletal pain—Citalopram—alcohol dependence	0.00159	0.00477	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00159	0.00476	CcSEcCtD
Eplerenone—Bronchitis—Acamprosate—alcohol dependence	0.00158	0.00474	CcSEcCtD
Eplerenone—Ventricular tachycardia—Citalopram—alcohol dependence	0.00157	0.00471	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—ADH1B—alcohol dependence	0.00154	0.0105	CbGpPWpGaD
Eplerenone—Influenza like illness—Citalopram—alcohol dependence	0.00152	0.00457	CcSEcCtD
Eplerenone—Angina pectoris—Naltrexone—alcohol dependence	0.00151	0.00454	CcSEcCtD
Eplerenone—Bronchitis—Naltrexone—alcohol dependence	0.00149	0.00448	CcSEcCtD
Eplerenone—NR3C2—digestive system—alcohol dependence	0.00149	0.032	CbGeAlD
Eplerenone—CYP3A5—Xenobiotics—CYP2E1—alcohol dependence	0.00149	0.0101	CbGpPWpGaD
Eplerenone—Hyperglycaemia—Acamprosate—alcohol dependence	0.00148	0.00445	CcSEcCtD
Eplerenone—Pneumonia—Acamprosate—alcohol dependence	0.00147	0.00442	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—ALDH3A2—alcohol dependence	0.00147	0.01	CbGpPWpGaD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—alcohol dependence	0.00147	0.00998	CbGpPWpGaD
Eplerenone—Depression—Acamprosate—alcohol dependence	0.00146	0.00438	CcSEcCtD
Eplerenone—CYP3A7-CYP3A51P—liver—alcohol dependence	0.00145	0.0311	CbGeAlD
Eplerenone—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00144	0.00433	CcSEcCtD
Eplerenone—Acute coronary syndrome—Acamprosate—alcohol dependence	0.00144	0.00433	CcSEcCtD
Eplerenone—Myocardial infarction—Acamprosate—alcohol dependence	0.00144	0.00431	CcSEcCtD
Eplerenone—CYP3A5—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00143	0.00972	CbGpPWpGaD
Eplerenone—Urinary tract infection—Acamprosate—alcohol dependence	0.00142	0.00427	CcSEcCtD
Eplerenone—CYP3A5—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.00142	0.00967	CbGpPWpGaD
Eplerenone—NR3C2—blood—alcohol dependence	0.00142	0.0305	CbGeAlD
Eplerenone—Gynaecomastia—Citalopram—alcohol dependence	0.0014	0.00421	CcSEcCtD
Eplerenone—NR3C2—midbrain—alcohol dependence	0.0014	0.0301	CbGeAlD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.0014	0.00953	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.0014	0.00953	CbGpPWpGaD
Eplerenone—CYP3A4—Aflatoxin activation and detoxification—GGT2—alcohol dependence	0.0014	0.00951	CbGpPWpGaD
Eplerenone—Haematuria—Acamprosate—alcohol dependence	0.0014	0.00419	CcSEcCtD
Eplerenone—Pneumonia—Naltrexone—alcohol dependence	0.00139	0.00418	CcSEcCtD
Eplerenone—Infestation—Naltrexone—alcohol dependence	0.00139	0.00416	CcSEcCtD
Eplerenone—Infestation NOS—Naltrexone—alcohol dependence	0.00139	0.00416	CcSEcCtD
Eplerenone—Depression—Naltrexone—alcohol dependence	0.00138	0.00415	CcSEcCtD
Eplerenone—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00137	0.0041	CcSEcCtD
Eplerenone—Asthenia—Disulfiram—alcohol dependence	0.00136	0.00408	CcSEcCtD
Eplerenone—Myocardial infarction—Naltrexone—alcohol dependence	0.00136	0.00408	CcSEcCtD
Eplerenone—Urinary tract infection—Naltrexone—alcohol dependence	0.00135	0.00404	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00134	0.00914	CbGpPWpGaD
Eplerenone—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00131	0.00393	CcSEcCtD
Eplerenone—Diabetes mellitus—Citalopram—alcohol dependence	0.00131	0.00393	CcSEcCtD
Eplerenone—Hypoaesthesia—Acamprosate—alcohol dependence	0.00131	0.00392	CcSEcCtD
Eplerenone—Pharyngitis—Acamprosate—alcohol dependence	0.0013	0.00392	CcSEcCtD
Eplerenone—Oedema peripheral—Acamprosate—alcohol dependence	0.00129	0.00389	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—MAOB—alcohol dependence	0.00128	0.00868	CbGpPWpGaD
Eplerenone—Dizziness—Disulfiram—alcohol dependence	0.00125	0.00376	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—ADH6—alcohol dependence	0.00124	0.00845	CbGpPWpGaD
Eplerenone—Pharyngitis—Naltrexone—alcohol dependence	0.00123	0.0037	CcSEcCtD
Eplerenone—NR3C2—endocrine gland—alcohol dependence	0.00123	0.0265	CbGeAlD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.00123	0.00836	CbGpPWpGaD
Eplerenone—Libido decreased—Citalopram—alcohol dependence	0.00123	0.00369	CcSEcCtD
Eplerenone—Tinnitus—Acamprosate—alcohol dependence	0.00123	0.00368	CcSEcCtD
Eplerenone—Connective tissue disorder—Naltrexone—alcohol dependence	0.00122	0.00367	CcSEcCtD
Eplerenone—Atrial fibrillation—Citalopram—alcohol dependence	0.0012	0.00361	CcSEcCtD
Eplerenone—Rash—Disulfiram—alcohol dependence	0.0012	0.00359	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.00119	0.00811	CbGpPWpGaD
Eplerenone—Headache—Disulfiram—alcohol dependence	0.00119	0.00356	CcSEcCtD
Eplerenone—NR3C2—testis—alcohol dependence	0.00117	0.0252	CbGeAlD
Eplerenone—Tinnitus—Naltrexone—alcohol dependence	0.00116	0.00348	CcSEcCtD
Eplerenone—Cardiac disorder—Naltrexone—alcohol dependence	0.00115	0.00346	CcSEcCtD
Eplerenone—NR3C2—nervous system—alcohol dependence	0.00115	0.0248	CbGeAlD
Eplerenone—Mental disorder—Acamprosate—alcohol dependence	0.00115	0.00346	CcSEcCtD
Eplerenone—Malnutrition—Acamprosate—alcohol dependence	0.00114	0.00343	CcSEcCtD
Eplerenone—Hyponatraemia—Citalopram—alcohol dependence	0.00114	0.00343	CcSEcCtD
Eplerenone—Disturbance in sexual arousal—Citalopram—alcohol dependence	0.00113	0.00339	CcSEcCtD
Eplerenone—Angiopathy—Naltrexone—alcohol dependence	0.00113	0.00339	CcSEcCtD
Eplerenone—Flatulence—Acamprosate—alcohol dependence	0.00113	0.00338	CcSEcCtD
Eplerenone—Mediastinal disorder—Naltrexone—alcohol dependence	0.00112	0.00336	CcSEcCtD
Eplerenone—NR3C2—liver—alcohol dependence	0.00111	0.0238	CbGeAlD
Eplerenone—NR3C2—central nervous system—alcohol dependence	0.00111	0.0238	CbGeAlD
Eplerenone—Back pain—Acamprosate—alcohol dependence	0.00111	0.00332	CcSEcCtD
Eplerenone—Muscle spasms—Acamprosate—alcohol dependence	0.0011	0.0033	CcSEcCtD
Eplerenone—Mental disorder—Naltrexone—alcohol dependence	0.00109	0.00327	CcSEcCtD
Eplerenone—NR3C2—cerebellum—alcohol dependence	0.00108	0.0233	CbGeAlD
Eplerenone—CYP11B2—Biological oxidations—ALDH2—alcohol dependence	0.00108	0.00738	CbGpPWpGaD
Eplerenone—Malnutrition—Naltrexone—alcohol dependence	0.00108	0.00325	CcSEcCtD
Eplerenone—CYP11B2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.00108	0.00734	CbGpPWpGaD
Eplerenone—Flatulence—Naltrexone—alcohol dependence	0.00107	0.0032	CcSEcCtD
Eplerenone—Ill-defined disorder—Acamprosate—alcohol dependence	0.00106	0.00319	CcSEcCtD
Eplerenone—Dehydration—Citalopram—alcohol dependence	0.00106	0.00318	CcSEcCtD
Eplerenone—Anaemia—Acamprosate—alcohol dependence	0.00106	0.00317	CcSEcCtD
Eplerenone—Back pain—Naltrexone—alcohol dependence	0.00105	0.00314	CcSEcCtD
Eplerenone—Angioedema—Acamprosate—alcohol dependence	0.00105	0.00314	CcSEcCtD
Eplerenone—Muscle spasms—Naltrexone—alcohol dependence	0.00104	0.00312	CcSEcCtD
Eplerenone—Orthostatic hypotension—Citalopram—alcohol dependence	0.00104	0.00312	CcSEcCtD
Eplerenone—Hypokalaemia—Citalopram—alcohol dependence	0.00104	0.00311	CcSEcCtD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—alcohol dependence	0.00103	0.00703	CbGpPWpGaD
Eplerenone—Malaise—Acamprosate—alcohol dependence	0.00103	0.0031	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—ADH1A—alcohol dependence	0.00103	0.00701	CbGpPWpGaD
Eplerenone—Syncope—Acamprosate—alcohol dependence	0.00103	0.00308	CcSEcCtD
Eplerenone—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00103	0.00308	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.00102	0.00693	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.00101	0.00689	CbGpPWpGaD
Eplerenone—Loss of consciousness—Acamprosate—alcohol dependence	0.00101	0.00302	CcSEcCtD
Eplerenone—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.001	0.00301	CcSEcCtD
Eplerenone—Ill-defined disorder—Naltrexone—alcohol dependence	0.001	0.00301	CcSEcCtD
Eplerenone—Cough—Acamprosate—alcohol dependence	0.000999	0.003	CcSEcCtD
Eplerenone—Angioedema—Naltrexone—alcohol dependence	0.000989	0.00297	CcSEcCtD
Eplerenone—Malaise—Naltrexone—alcohol dependence	0.000976	0.00293	CcSEcCtD
Eplerenone—Eosinophilia—Citalopram—alcohol dependence	0.000975	0.00293	CcSEcCtD
Eplerenone—Myalgia—Acamprosate—alcohol dependence	0.000974	0.00292	CcSEcCtD
Eplerenone—Arthralgia—Acamprosate—alcohol dependence	0.000974	0.00292	CcSEcCtD
Eplerenone—Chest pain—Acamprosate—alcohol dependence	0.000974	0.00292	CcSEcCtD
Eplerenone—Syncope—Naltrexone—alcohol dependence	0.000971	0.00291	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.000967	0.0029	CcSEcCtD
Eplerenone—Discomfort—Acamprosate—alcohol dependence	0.000963	0.00289	CcSEcCtD
Eplerenone—Angina pectoris—Citalopram—alcohol dependence	0.000959	0.00288	CcSEcCtD
Eplerenone—Loss of consciousness—Naltrexone—alcohol dependence	0.000952	0.00286	CcSEcCtD
Eplerenone—Bronchitis—Citalopram—alcohol dependence	0.000947	0.00284	CcSEcCtD
Eplerenone—Cough—Naltrexone—alcohol dependence	0.000945	0.00284	CcSEcCtD
Eplerenone—CYP3A5—pancreas—alcohol dependence	0.000943	0.0203	CbGeAlD
Eplerenone—Infection—Acamprosate—alcohol dependence	0.000928	0.00278	CcSEcCtD
Eplerenone—Arthralgia—Naltrexone—alcohol dependence	0.000922	0.00277	CcSEcCtD
Eplerenone—Chest pain—Naltrexone—alcohol dependence	0.000922	0.00277	CcSEcCtD
Eplerenone—Myalgia—Naltrexone—alcohol dependence	0.000922	0.00277	CcSEcCtD
Eplerenone—Shock—Acamprosate—alcohol dependence	0.000919	0.00276	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.000915	0.00275	CcSEcCtD
Eplerenone—Upper respiratory tract infection—Citalopram—alcohol dependence	0.000915	0.00275	CcSEcCtD
Eplerenone—Discomfort—Naltrexone—alcohol dependence	0.000911	0.00273	CcSEcCtD
Eplerenone—Skin disorder—Acamprosate—alcohol dependence	0.000907	0.00272	CcSEcCtD
Eplerenone—Hyperhidrosis—Acamprosate—alcohol dependence	0.000903	0.00271	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—ADH6—alcohol dependence	0.000898	0.00611	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000888	0.00604	CbGpPWpGaD
Eplerenone—Hyperglycaemia—Citalopram—alcohol dependence	0.000888	0.00267	CcSEcCtD
Eplerenone—Pneumonia—Citalopram—alcohol dependence	0.000883	0.00265	CcSEcCtD
Eplerenone—NR3C2—brain—alcohol dependence	0.000881	0.0189	CbGeAlD
Eplerenone—Infection—Naltrexone—alcohol dependence	0.000878	0.00263	CcSEcCtD
Eplerenone—Infestation NOS—Citalopram—alcohol dependence	0.000878	0.00263	CcSEcCtD
Eplerenone—Infestation—Citalopram—alcohol dependence	0.000878	0.00263	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—ADH4—alcohol dependence	0.000876	0.00596	CbGpPWpGaD
Eplerenone—Depression—Citalopram—alcohol dependence	0.000875	0.00263	CcSEcCtD
Eplerenone—CYP11B2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000874	0.00595	CbGpPWpGaD
Eplerenone—Hypotension—Acamprosate—alcohol dependence	0.000873	0.00262	CcSEcCtD
Eplerenone—Shock—Naltrexone—alcohol dependence	0.000869	0.00261	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—CYP2E1—alcohol dependence	0.000867	0.0059	CbGpPWpGaD
Eplerenone—Nervous system disorder—Naltrexone—alcohol dependence	0.000867	0.0026	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000866	0.00589	CbGpPWpGaD
Eplerenone—Acute coronary syndrome—Citalopram—alcohol dependence	0.000865	0.0026	CcSEcCtD
Eplerenone—Neuropathy peripheral—Citalopram—alcohol dependence	0.00086	0.00258	CcSEcCtD
Eplerenone—Myocardial infarction—Citalopram—alcohol dependence	0.00086	0.00258	CcSEcCtD
Eplerenone—Skin disorder—Naltrexone—alcohol dependence	0.000858	0.00258	CcSEcCtD
Eplerenone—CYP11B2—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000855	0.00582	CbGpPWpGaD
Eplerenone—Hyperhidrosis—Naltrexone—alcohol dependence	0.000854	0.00256	CcSEcCtD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000854	0.00581	CbGpPWpGaD
Eplerenone—Urinary tract infection—Citalopram—alcohol dependence	0.000853	0.00256	CcSEcCtD
Eplerenone—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.000851	0.00255	CcSEcCtD
Eplerenone—Insomnia—Acamprosate—alcohol dependence	0.000845	0.00253	CcSEcCtD
Eplerenone—CYP3A7—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000843	0.00573	CbGpPWpGaD
Eplerenone—Haematuria—Citalopram—alcohol dependence	0.000837	0.00251	CcSEcCtD
Eplerenone—Dyspnoea—Acamprosate—alcohol dependence	0.000833	0.0025	CcSEcCtD
Eplerenone—Hepatobiliary disease—Citalopram—alcohol dependence	0.00083	0.00249	CcSEcCtD
Eplerenone—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—alcohol dependence	0.000826	0.00562	CbGpPWpGaD
Eplerenone—Dyspepsia—Acamprosate—alcohol dependence	0.000822	0.00247	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.000806	0.00242	CcSEcCtD
Eplerenone—CYP3A5—digestive system—alcohol dependence	0.000806	0.0173	CbGeAlD
Eplerenone—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.000805	0.00242	CcSEcCtD
Eplerenone—Insomnia—Naltrexone—alcohol dependence	0.000799	0.0024	CcSEcCtD
Eplerenone—Pain—Acamprosate—alcohol dependence	0.000799	0.0024	CcSEcCtD
Eplerenone—Constipation—Acamprosate—alcohol dependence	0.000799	0.0024	CcSEcCtD
Eplerenone—CYP11B2—Biological oxidations—GGT1—alcohol dependence	0.000796	0.00542	CbGpPWpGaD
Eplerenone—Dyspnoea—Naltrexone—alcohol dependence	0.000788	0.00236	CcSEcCtD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ADH6—alcohol dependence	0.000786	0.00535	CbGpPWpGaD
Eplerenone—Hypoaesthesia—Citalopram—alcohol dependence	0.000784	0.00235	CcSEcCtD
Eplerenone—Pharyngitis—Citalopram—alcohol dependence	0.000782	0.00235	CcSEcCtD
Eplerenone—Urinary tract disorder—Citalopram—alcohol dependence	0.000778	0.00234	CcSEcCtD
Eplerenone—Oedema peripheral—Citalopram—alcohol dependence	0.000776	0.00233	CcSEcCtD
Eplerenone—Connective tissue disorder—Citalopram—alcohol dependence	0.000774	0.00232	CcSEcCtD
Eplerenone—Urethral disorder—Citalopram—alcohol dependence	0.000772	0.00232	CcSEcCtD
Eplerenone—Testosterone—MAOA—alcohol dependence	0.00077	0.303	CrCbGaD
Eplerenone—Feeling abnormal—Acamprosate—alcohol dependence	0.00077	0.00231	CcSEcCtD
Eplerenone—CYP3A5—blood—alcohol dependence	0.000767	0.0165	CbGeAlD
Eplerenone—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000764	0.00229	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000763	0.00229	CcSEcCtD
Eplerenone—Fatigue—Naltrexone—alcohol dependence	0.000762	0.00229	CcSEcCtD
Eplerenone—Constipation—Naltrexone—alcohol dependence	0.000756	0.00227	CcSEcCtD
Eplerenone—Pain—Naltrexone—alcohol dependence	0.000756	0.00227	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—ADH7—alcohol dependence	0.000744	0.00506	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—ADH1A—alcohol dependence	0.000744	0.00506	CbGpPWpGaD
Eplerenone—Abdominal pain—Acamprosate—alcohol dependence	0.000738	0.00222	CcSEcCtD
Eplerenone—Body temperature increased—Acamprosate—alcohol dependence	0.000738	0.00222	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000736	0.00501	CbGpPWpGaD
Eplerenone—Tinnitus—Citalopram—alcohol dependence	0.000735	0.0022	CcSEcCtD
Eplerenone—NR3C2—Gene Expression—CCAR1—alcohol dependence	0.000733	0.00499	CbGpPWpGaD
Eplerenone—Cardiac disorder—Citalopram—alcohol dependence	0.000731	0.00219	CcSEcCtD
Eplerenone—Flushing—Citalopram—alcohol dependence	0.000731	0.00219	CcSEcCtD
Eplerenone—Feeling abnormal—Naltrexone—alcohol dependence	0.000728	0.00219	CcSEcCtD
Eplerenone—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000723	0.00217	CcSEcCtD
Eplerenone—Angiopathy—Citalopram—alcohol dependence	0.000715	0.00215	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—GGT2—alcohol dependence	0.000714	0.00486	CbGpPWpGaD
Eplerenone—CYP11B2—Biological oxidations—MAOA—alcohol dependence	0.000713	0.00485	CbGpPWpGaD
Eplerenone—Mediastinal disorder—Citalopram—alcohol dependence	0.00071	0.00213	CcSEcCtD
Eplerenone—Abdominal pain—Naltrexone—alcohol dependence	0.000698	0.0021	CcSEcCtD
Eplerenone—Body temperature increased—Naltrexone—alcohol dependence	0.000698	0.0021	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000692	0.00471	CbGpPWpGaD
Eplerenone—CYP3A4—Xenobiotics—CYP2E1—alcohol dependence	0.000691	0.0047	CbGpPWpGaD
Eplerenone—Mental disorder—Citalopram—alcohol dependence	0.00069	0.00207	CcSEcCtD
Eplerenone—Malnutrition—Citalopram—alcohol dependence	0.000686	0.00206	CcSEcCtD
Eplerenone—Flatulence—Citalopram—alcohol dependence	0.000676	0.00203	CcSEcCtD
Eplerenone—Asthenia—Acamprosate—alcohol dependence	0.00067	0.00201	CcSEcCtD
Eplerenone—CYP3A5—endocrine gland—alcohol dependence	0.000666	0.0143	CbGeAlD
Eplerenone—CYP3A4—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.000665	0.00452	CbGpPWpGaD
Eplerenone—Back pain—Citalopram—alcohol dependence	0.000664	0.00199	CcSEcCtD
Eplerenone—CYP3A4—Aflatoxin activation and detoxification—GGT1—alcohol dependence	0.000661	0.0045	CbGpPWpGaD
Eplerenone—Pruritus—Acamprosate—alcohol dependence	0.000661	0.00198	CcSEcCtD
Eplerenone—Muscle spasms—Citalopram—alcohol dependence	0.00066	0.00198	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—ADH1B—alcohol dependence	0.000653	0.00444	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1A—alcohol dependence	0.000651	0.00443	CbGpPWpGaD
Eplerenone—Diarrhoea—Acamprosate—alcohol dependence	0.000639	0.00192	CcSEcCtD
Eplerenone—Ill-defined disorder—Citalopram—alcohol dependence	0.000636	0.00191	CcSEcCtD
Eplerenone—Anaemia—Citalopram—alcohol dependence	0.000634	0.0019	CcSEcCtD
Eplerenone—Asthenia—Naltrexone—alcohol dependence	0.000634	0.0019	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—ADH4—alcohol dependence	0.000633	0.00431	CbGpPWpGaD
Eplerenone—Angioedema—Citalopram—alcohol dependence	0.000627	0.00188	CcSEcCtD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000626	0.00426	CbGpPWpGaD
Eplerenone—Pruritus—Naltrexone—alcohol dependence	0.000625	0.00188	CcSEcCtD
Eplerenone—Malaise—Citalopram—alcohol dependence	0.000619	0.00186	CcSEcCtD
Eplerenone—Dizziness—Acamprosate—alcohol dependence	0.000618	0.00185	CcSEcCtD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000617	0.0042	CbGpPWpGaD
Eplerenone—Syncope—Citalopram—alcohol dependence	0.000615	0.00185	CcSEcCtD
Eplerenone—CYP3A5—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000609	0.00414	CbGpPWpGaD
Eplerenone—Diarrhoea—Naltrexone—alcohol dependence	0.000605	0.00181	CcSEcCtD
Eplerenone—CYP3A4—digestive system—alcohol dependence	0.000605	0.013	CbGeAlD
Eplerenone—Loss of consciousness—Citalopram—alcohol dependence	0.000603	0.00181	CcSEcCtD
Eplerenone—CYP3A5—liver—alcohol dependence	0.0006	0.0129	CbGeAlD
Eplerenone—Cough—Citalopram—alcohol dependence	0.000599	0.0018	CcSEcCtD
Eplerenone—Vomiting—Acamprosate—alcohol dependence	0.000594	0.00178	CcSEcCtD
Eplerenone—Rash—Acamprosate—alcohol dependence	0.000589	0.00177	CcSEcCtD
Eplerenone—Dermatitis—Acamprosate—alcohol dependence	0.000588	0.00177	CcSEcCtD
Eplerenone—Headache—Acamprosate—alcohol dependence	0.000585	0.00176	CcSEcCtD
Eplerenone—Dizziness—Naltrexone—alcohol dependence	0.000584	0.00175	CcSEcCtD
Eplerenone—Arthralgia—Citalopram—alcohol dependence	0.000584	0.00175	CcSEcCtD
Eplerenone—Chest pain—Citalopram—alcohol dependence	0.000584	0.00175	CcSEcCtD
Eplerenone—Myalgia—Citalopram—alcohol dependence	0.000584	0.00175	CcSEcCtD
Eplerenone—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.00058	0.00174	CcSEcCtD
Eplerenone—Discomfort—Citalopram—alcohol dependence	0.000577	0.00173	CcSEcCtD
Eplerenone—CYP3A4—blood—alcohol dependence	0.000576	0.0124	CbGeAlD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.00057	0.00387	CbGpPWpGaD
Eplerenone—Vomiting—Naltrexone—alcohol dependence	0.000562	0.00169	CcSEcCtD
Eplerenone—Rash—Naltrexone—alcohol dependence	0.000557	0.00167	CcSEcCtD
Eplerenone—Dermatitis—Naltrexone—alcohol dependence	0.000557	0.00167	CcSEcCtD
Eplerenone—Infection—Citalopram—alcohol dependence	0.000556	0.00167	CcSEcCtD
Eplerenone—Nausea—Acamprosate—alcohol dependence	0.000555	0.00166	CcSEcCtD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—alcohol dependence	0.000554	0.00377	CbGpPWpGaD
Eplerenone—Headache—Naltrexone—alcohol dependence	0.000554	0.00166	CcSEcCtD
Eplerenone—Shock—Citalopram—alcohol dependence	0.000551	0.00165	CcSEcCtD
Eplerenone—Nervous system disorder—Citalopram—alcohol dependence	0.000549	0.00165	CcSEcCtD
Eplerenone—Skin disorder—Citalopram—alcohol dependence	0.000544	0.00163	CcSEcCtD
Eplerenone—Hyperhidrosis—Citalopram—alcohol dependence	0.000541	0.00162	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—MAOB—alcohol dependence	0.000541	0.00368	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—ADH7—alcohol dependence	0.000538	0.00366	CbGpPWpGaD
Eplerenone—Nausea—Naltrexone—alcohol dependence	0.000525	0.00157	CcSEcCtD
Eplerenone—Hypotension—Citalopram—alcohol dependence	0.000523	0.00157	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—MAOB—alcohol dependence	0.000522	0.00355	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GGT2—alcohol dependence	0.000516	0.00351	CbGpPWpGaD
Eplerenone—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.00051	0.00153	CcSEcCtD
Eplerenone—Insomnia—Citalopram—alcohol dependence	0.000506	0.00152	CcSEcCtD
Eplerenone—CYP11B2—Metabolism—ADH6—alcohol dependence	0.000501	0.00341	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.0005	0.0034	CbGpPWpGaD
Eplerenone—CYP3A4—endocrine gland—alcohol dependence	0.0005	0.0107	CbGeAlD
Eplerenone—Dyspnoea—Citalopram—alcohol dependence	0.000499	0.0015	CcSEcCtD
Eplerenone—Dyspepsia—Citalopram—alcohol dependence	0.000493	0.00148	CcSEcCtD
Eplerenone—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000483	0.00145	CcSEcCtD
Eplerenone—Fatigue—Citalopram—alcohol dependence	0.000483	0.00145	CcSEcCtD
Eplerenone—Constipation—Citalopram—alcohol dependence	0.000479	0.00144	CcSEcCtD
Eplerenone—Pain—Citalopram—alcohol dependence	0.000479	0.00144	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—ADH1B—alcohol dependence	0.000472	0.00321	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ADH7—alcohol dependence	0.000471	0.0032	CbGpPWpGaD
Eplerenone—CYP3A4—nervous system—alcohol dependence	0.000468	0.01	CbGeAlD
Eplerenone—CYP11B2—Biological oxidations—POMC—alcohol dependence	0.000464	0.00316	CbGpPWpGaD
Eplerenone—Feeling abnormal—Citalopram—alcohol dependence	0.000461	0.00138	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—ALDH2—alcohol dependence	0.00046	0.00313	CbGpPWpGaD
Eplerenone—Gastrointestinal pain—Citalopram—alcohol dependence	0.000458	0.00137	CcSEcCtD
Eplerenone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000457	0.00311	CbGpPWpGaD
Eplerenone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000452	0.00307	CbGpPWpGaD
Eplerenone—CYP3A4—liver—alcohol dependence	0.00045	0.00967	CbGeAlD
Eplerenone—CYP3A4—central nervous system—alcohol dependence	0.00045	0.00967	CbGeAlD
Eplerenone—CYP3A4—Tryptophan metabolism—ALDH2—alcohol dependence	0.000444	0.00302	CbGpPWpGaD
Eplerenone—Abdominal pain—Citalopram—alcohol dependence	0.000443	0.00133	CcSEcCtD
Eplerenone—Body temperature increased—Citalopram—alcohol dependence	0.000443	0.00133	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—ADH6—alcohol dependence	0.000418	0.00284	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ADH1A—alcohol dependence	0.000415	0.00282	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—alcohol dependence	0.000413	0.00281	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000412	0.0028	CbGpPWpGaD
Eplerenone—Asthenia—Citalopram—alcohol dependence	0.000402	0.00121	CcSEcCtD
Eplerenone—Pruritus—Citalopram—alcohol dependence	0.000396	0.00119	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—MAOB—alcohol dependence	0.000391	0.00266	CbGpPWpGaD
Eplerenone—Diarrhoea—Citalopram—alcohol dependence	0.000383	0.00115	CcSEcCtD
Eplerenone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000371	0.00252	CbGpPWpGaD
Eplerenone—Dizziness—Citalopram—alcohol dependence	0.00037	0.00111	CcSEcCtD
Eplerenone—CYP3A7—Biological oxidations—CYP2E1—alcohol dependence	0.000368	0.0025	CbGpPWpGaD
Eplerenone—CYP3A7—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000363	0.00247	CbGpPWpGaD
Eplerenone—Vomiting—Citalopram—alcohol dependence	0.000356	0.00107	CcSEcCtD
Eplerenone—CYP3A4—Tryptophan metabolism—CYP2E1—alcohol dependence	0.000355	0.00241	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ADH4—alcohol dependence	0.000353	0.0024	CbGpPWpGaD
Eplerenone—Rash—Citalopram—alcohol dependence	0.000353	0.00106	CcSEcCtD
Eplerenone—Dermatitis—Citalopram—alcohol dependence	0.000353	0.00106	CcSEcCtD
Eplerenone—Headache—Citalopram—alcohol dependence	0.000351	0.00105	CcSEcCtD
Eplerenone—CYP3A4—Biological oxidations—ADH1A—alcohol dependence	0.000346	0.00235	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—alcohol dependence	0.000342	0.00233	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—GGT1—alcohol dependence	0.000338	0.0023	CbGpPWpGaD
Eplerenone—Nausea—Citalopram—alcohol dependence	0.000333	0.000998	CcSEcCtD
Eplerenone—CYP3A5—Biological oxidations—ALDH2—alcohol dependence	0.000332	0.00226	CbGpPWpGaD
Eplerenone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000331	0.00225	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000306	0.00208	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—MAOA—alcohol dependence	0.000303	0.00206	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ADH7—alcohol dependence	0.0003	0.00204	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ADH4—alcohol dependence	0.000294	0.002	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—alcohol dependence	0.000291	0.00198	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GGT2—alcohol dependence	0.000288	0.00196	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—alcohol dependence	0.000287	0.00195	CbGpPWpGaD
Eplerenone—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—alcohol dependence	0.000283	0.00193	CbGpPWpGaD
Eplerenone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000268	0.00182	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—CYP2E1—alcohol dependence	0.000266	0.00181	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ADH1B—alcohol dependence	0.000263	0.00179	CbGpPWpGaD
Eplerenone—CYP3A5—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000262	0.00178	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ADH7—alcohol dependence	0.00025	0.0017	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—GGT1—alcohol dependence	0.000244	0.00166	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GGT2—alcohol dependence	0.00024	0.00163	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	0.000233	0.00158	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	0.000219	0.00149	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—MAOA—alcohol dependence	0.000219	0.00149	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—MAOB—alcohol dependence	0.000218	0.00148	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ADH6—alcohol dependence	0.000213	0.00145	CbGpPWpGaD
Eplerenone—CYP3A7—Biological oxidations—POMC—alcohol dependence	0.000197	0.00134	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	0.000191	0.0013	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—ALDH2—alcohol dependence	0.000185	0.00126	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—MAOB—alcohol dependence	0.000182	0.00124	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	0.000178	0.00121	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ADH1A—alcohol dependence	0.000176	0.0012	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GOT2—alcohol dependence	0.000158	0.00107	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	0.000155	0.00105	CbGpPWpGaD
Eplerenone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	0.000154	0.00105	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ADH6—alcohol dependence	0.000154	0.00105	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ADH4—alcohol dependence	0.00015	0.00102	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—CYP2E1—alcohol dependence	0.000148	0.00101	CbGpPWpGaD
Eplerenone—CYP3A5—Biological oxidations—POMC—alcohol dependence	0.000142	0.000969	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GGT1—alcohol dependence	0.000136	0.000926	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—GOT1—alcohol dependence	0.000136	0.000926	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ADH7—alcohol dependence	0.000127	0.000866	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ADH1A—alcohol dependence	0.000127	0.000866	CbGpPWpGaD
Eplerenone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	0.000125	0.000848	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	0.000124	0.000841	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GGT2—alcohol dependence	0.000122	0.00083	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—MAOA—alcohol dependence	0.000122	0.00083	CbGpPWpGaD
Eplerenone—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000122	0.000829	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	0.000118	0.000805	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—GGT1—alcohol dependence	0.000113	0.000772	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ADH1B—alcohol dependence	0.000112	0.000759	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ADH4—alcohol dependence	0.000108	0.000736	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—MAOA—alcohol dependence	0.000102	0.000692	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MAOB—alcohol dependence	9.25e-05	0.000629	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ADH7—alcohol dependence	9.2e-05	0.000626	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GGT2—alcohol dependence	8.82e-05	0.0006	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ADH1B—alcohol dependence	8.07e-05	0.000549	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—POMC—alcohol dependence	7.94e-05	0.00054	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—ALDH2—alcohol dependence	7.87e-05	0.000535	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADH6—alcohol dependence	7.14e-05	0.000486	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GOT2—alcohol dependence	6.69e-05	0.000455	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MAOB—alcohol dependence	6.69e-05	0.000455	CbGpPWpGaD
Eplerenone—CYP3A4—Biological oxidations—POMC—alcohol dependence	6.62e-05	0.00045	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—CYP2E1—alcohol dependence	6.29e-05	0.000428	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADH1A—alcohol dependence	5.92e-05	0.000403	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GGT1—alcohol dependence	5.77e-05	0.000393	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—GOT1—alcohol dependence	5.77e-05	0.000393	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—ALDH2—alcohol dependence	5.69e-05	0.000387	CbGpPWpGaD
Eplerenone—CYP11B2—Metabolism—EP300—alcohol dependence	5.27e-05	0.000358	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—MAOA—alcohol dependence	5.17e-05	0.000352	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADH4—alcohol dependence	5.03e-05	0.000342	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GOT2—alcohol dependence	4.83e-05	0.000329	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—CYP2E1—alcohol dependence	4.55e-05	0.000309	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADH7—alcohol dependence	4.28e-05	0.000291	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GOT1—alcohol dependence	4.17e-05	0.000284	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—GGT1—alcohol dependence	4.17e-05	0.000284	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GGT2—alcohol dependence	4.1e-05	0.000279	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ADH1B—alcohol dependence	3.75e-05	0.000255	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—MAOA—alcohol dependence	3.74e-05	0.000254	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—POMC—alcohol dependence	3.37e-05	0.000229	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MAOB—alcohol dependence	3.11e-05	0.000211	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.64e-05	0.00018	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—POMC—alcohol dependence	2.43e-05	0.000166	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GOT2—alcohol dependence	2.25e-05	0.000153	CbGpPWpGaD
Eplerenone—CYP3A7—Metabolism—EP300—alcohol dependence	2.23e-05	0.000152	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.11e-05	0.000144	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GOT1—alcohol dependence	1.94e-05	0.000132	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—GGT1—alcohol dependence	1.94e-05	0.000132	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—MAOA—alcohol dependence	1.74e-05	0.000118	CbGpPWpGaD
Eplerenone—CYP3A5—Metabolism—EP300—alcohol dependence	1.62e-05	0.00011	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—POMC—alcohol dependence	1.13e-05	7.7e-05	CbGpPWpGaD
Eplerenone—CYP3A4—Metabolism—EP300—alcohol dependence	7.51e-06	5.11e-05	CbGpPWpGaD
